These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2657246)
21. [Effects of thymopentin and recombinant interferon alpha 2A on the biochemiluminescence of neutrophil granulocytes in subjects with HIV infections]. Latorre A; Romagno D; Palumbo A; Dammacco F G Clin Med; 1987; 68(6-7):351-5. PubMed ID: 3308608 [No Abstract] [Full Text] [Related]
22. Restoration of the impaired lymphocyte stimulation in old people by thymopoietin pentapeptide. Verhaegen H; De Cock W; De Cree J; Goldstein G J Clin Lab Immunol; 1981 Sep; 6(2):103-5. PubMed ID: 7026790 [TBL] [Abstract][Full Text] [Related]
23. Immunologic effects of long-term thymopentin treatment in patients with HIV-induced lymphadenopathy syndrome. Silvestris F; Gernone A; Frassanito MA; Dammacco F J Lab Clin Med; 1989 Feb; 113(2):139-44. PubMed ID: 2644387 [TBL] [Abstract][Full Text] [Related]
24. Biologically active analogs of thymopentin with enhanced enzymatic stability. Heavner GA; Kroon DJ; Audhya T; Goldstein G Peptides; 1986; 7(6):1015-9. PubMed ID: 3031628 [TBL] [Abstract][Full Text] [Related]
25. The influence of thymus hormones on the NK cells activity. Giełdanowski J; Lemmel EM; Błaszczyk B Arch Immunol Ther Exp (Warsz); 1987; 35(5):657-61. PubMed ID: 3332069 [TBL] [Abstract][Full Text] [Related]
26. Thymopoietin and thymopentin enhance the levels of ACTH, beta-endorphin and beta-lipotropin from rat pituitary cells in vitro. Malaise MG; Hazee-Hagelstein MT; Reuter AM; Vrinds-Gevaert Y; Goldstein G; Franchimont P Acta Endocrinol (Copenh); 1987 Aug; 115(4):455-60. PubMed ID: 2820173 [TBL] [Abstract][Full Text] [Related]
28. In vivo enhancement of NK-cell activity by thymopentin. Hu C; Radelli L; Scorza R; Bonara P; Perego R; Fantuzzi G Int J Immunopharmacol; 1990; 12(2):193-7. PubMed ID: 2184134 [TBL] [Abstract][Full Text] [Related]
29. The effect of TP-5 and its analogs on skin grafts in mice. Szende B; Kisfaludy L; Lapis K; Dénes L; Szporny L; Nyéke O; Schön I; Hajós G; Ember J; Constantin M J Immunopharmacol; 1985; 7(1):67-78. PubMed ID: 3891868 [TBL] [Abstract][Full Text] [Related]
30. Effect of immunomodulator thymopentin on impaired seroresponse to influenza vaccine in patients on haemodialysis. Beyer WE; Noordzij TC; Kramer P; Diderich PP; Op den Hoek CT; Janssen J; Masurel N; Weimar W Nephron; 1990; 54(4):296-301. PubMed ID: 2183079 [TBL] [Abstract][Full Text] [Related]
31. Immunostimulation by TP-5 in immunocompromised patients and animals--current status of investigation. Waymack JP; Alexander JW Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):225-32. PubMed ID: 3539496 [TBL] [Abstract][Full Text] [Related]
32. Contrasting effects of thymopentin and splenopentin on the capacity of female mice to reject syngeneic male skin. Goldberg EH; Goldstein G; Harman DB; Boyse EA Transplantation; 1984 Jul; 38(1):52-5. PubMed ID: 6377611 [TBL] [Abstract][Full Text] [Related]
33. Immunokinetics of a single dose of thymopoietin pentapeptide. Di Perri T; Laghi Pasini F; Auteri A J Immunopharmacol; 1980; 2(4):567-72. PubMed ID: 7009760 [TBL] [Abstract][Full Text] [Related]
34. Immunomodulation in infection caused by human immunodeficiency virus. Phair JP J Lab Clin Med; 1989 Feb; 113(2):135-6. PubMed ID: 2644386 [No Abstract] [Full Text] [Related]
35. In vitro effects of thymopentin on the gamma-interferon production by peripheral blood mononuclear cells from normal subjects and from patients with rheumatoid arthritis. Malaise MG; Bastings M; Reuter AM; Vrindts-Gevaert Y; Bernier J; Sondag D; Frère MC; Goldstein G; Franchimont P Immunol Lett; 1987 Aug; 15(4):323-7. PubMed ID: 3121499 [TBL] [Abstract][Full Text] [Related]
36. Experiences with immunomodulant agents in HIV infections. Lazzarin A; Barcellini W; Uberti Foppa C; Borghi MO; Franzetti R; Cinque P; Moroni M Acta Haematol; 1987; 78 Suppl 1():84-90. PubMed ID: 3124453 [TBL] [Abstract][Full Text] [Related]
37. Influence of thymopentin on postsurgical immune deficiency: a clinical pilot study. Faist E; Riedel A; Bolla K Int J Clin Pharmacol Res; 1987; 7(1):83-7. PubMed ID: 3294617 [TBL] [Abstract][Full Text] [Related]
38. Thymopentin treatment in AIDS and pre-AIDS patients. Clumeck N; Cran S; Van de Perre P; Mascart-Lemone F; Duchateau J; Bolla K Surv Immunol Res; 1985; 4 Suppl 1():58-62. PubMed ID: 3898293 [TBL] [Abstract][Full Text] [Related]
39. Effect of the TP5 analogue of thymopoietin on the rejection of male skin by aged and thymectomized female mice. Goldberg EH; Goldstein G; Boyse EA; Scheid MP Immunogenetics; 1981; 13(3):201-4. PubMed ID: 7024116 [TBL] [Abstract][Full Text] [Related]
40. Regulatory influence of thymopentin on splenic T cell sets of thymectomized and aged mice. Newcomb EW; Goldberg EH; de Sousa M; Goldstein G; Boyse EA; Scheid MP Transplantation; 1985 Nov; 40(5):520-7. PubMed ID: 3904090 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]